新冠药物概念持续走强,截至发稿,中国医药三连板,仟源医药大涨18%,海辰药业、舒泰神、广生堂等纷纷跟涨。中国医药发布公告称,与某跨国制药公司新冠病毒治疗药物合作事宜正在沟通洽谈中。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.